BioNTech
phase trial | BioNTech
Company
Deck Type
Sector
Industry
Deck date
November 2020
Slide
7 of 25
Related slides by other companies
23andMe
Investor Presentation
January 2024
speed our lead program progressed from discovery to the clinic in years i | 23andMe
AstraZeneca
Results
April 2023
rare disease highlights pioneering in rare neurology to improve patient outcomes registry complete terminal complement inhibition patients on low dose after year potential best in class weekly self | AstraZeneca
AstraZeneca
Results
February 2021
building new standard of care | AstraZeneca
ATAI
Investor Presentation
April 2023
summary has previously shown pro cognitive effects in | ATAI
Other recent decks by BioNTech
See all presentations (12 decks)
Investor Presentation
August 2022
Results
August 2022
Investor Day
June 2022
Results
March 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights